AVDL
Neuberger Berman Group’s Avadel Pharmaceuticals AVDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6M | Buy |
678,116
+1,484
| +0.2% | +$13.1K | ﹤0.01% | 913 |
|
|
2025
Q1 | $5.3M | Buy |
676,632
+192,487
| +40% | +$1.51M | ﹤0.01% | 921 |
|
|
2024
Q4 | $5.09M | Buy |
+484,145
| New | +$5.09M | ﹤0.01% | 960 |
|
|
2014
Q4 | – | Sell |
-63,300
| Closed | -$905K | – | 1637 |
|
|
2014
Q3 | $905K | Sell |
63,300
-16,600
| -21% | -$237K | ﹤0.01% | 1267 |
|
|
2014
Q2 | $1.2M | Buy |
79,900
+2,900
| +4% | +$43.5K | ﹤0.01% | 1219 |
|
|
2014
Q1 | $1.03M | Buy |
+77,000
| New | +$1.03M | ﹤0.01% | 1210 |
|